Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.

Services Sector Most Active: J.C. Penney Company (NYSE:JCP), Sirius XM Holdings (NASDAQ:SIRI), McDonald’s Corporation (NYSE:MCD), Rite Aid (NYSE:RAD)

J.C. Penney Company, Inc. (NYSE:JCP) received a vote of confidence and a rare Wall Street upgrade on Tuesday. The Plano-based department store was labeled an “American comeback story” by Citigroup’s retail analyst Oliver Chen, who upgraded the retailer’s stock from “neutral” to “buy” on Tuesday. J.C. Penney Company, Inc. (NYSE:JCP) stock performance was 2.97% in…

Read More

Stock in News: What Apple (NASDAQ AAPL) Watch Price Means In Terms of Watch Sales

Apple (NASDAQ AAPL) introduced a new line of product on Monday. The Cupertino based technology company came up with the Apple Watch product which is the newest product in the wearable technology segment. Amid much speculation and expectancy, Apple showed the features and specifications of the product, along with the price range. Despite the let…

Read More

BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Myriad Genetics (NASDAQ:MYGN) is lower after the molecular diagnostic company disclosed in a regulatory filing Tuesday that the U.S. District Court for the District of Utah has denied the company’s motion for preliminary injunctive relief against Ambry Genetics’s sale of certain testing services that MYGN believes infringes on its patents. Shares are down 9.80% at…

Read More